These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35110381)

  • 41. Genetic effects of ATP1A2 in familial hemiplegic migraine type II and animal models.
    Gritz SM; Radcliffe RA
    Hum Genomics; 2013 Apr; 7(1):8. PubMed ID: 23561701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study.
    Rosewich H; Thiele H; Ohlenbusch A; Maschke U; Altmüller J; Frommolt P; Zirn B; Ebinger F; Siemes H; Nürnberg P; Brockmann K; Gärtner J
    Lancet Neurol; 2012 Sep; 11(9):764-73. PubMed ID: 22850527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Familial hemiplegic migraine is associated with febrile seizures in an FHM2 family with a novel de novo ATP1A2 mutation.
    de Vries B; Stam AH; Kirkpatrick M; Vanmolkot KR; Koenderink JB; van den Heuvel JJ; Stunnenberg B; Goudie D; Shetty J; Jain V; van Vark J; Terwindt GM; Frants RR; Haan J; van den Maagdenberg AM; Ferrari MD
    Epilepsia; 2009 Nov; 50(11):2503-4. PubMed ID: 19874388
    [No Abstract]   [Full Text] [Related]  

  • 44. Prolonged sporadic hemiplegic migraine associated with a novel de novo missense ATP1A2 gene mutation.
    De Sanctis S; Grieco GS; Breda L; Casali C; Nozzi M; Del Torto M; Chiarelli F; Verrotti A
    Headache; 2011 Mar; 51(3):447-450. PubMed ID: 21352219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spatially clustering de novo variants in CYFIP2, encoding the cytoplasmic FMRP interacting protein 2, cause intellectual disability and seizures.
    Zweier M; Begemann A; McWalter K; Cho MT; Abela L; Banka S; Behring B; Berger A; Brown CW; Carneiro M; Chen J; Cooper GM; ; Finnila CR; Guillen Sacoto MJ; Henderson A; Hüffmeier U; Joset P; Kerr B; Lesca G; Leszinski GS; McDermott JH; Meltzer MR; Monaghan KG; Mostafavi R; Õunap K; Plecko B; Powis Z; Purcarin G; Reimand T; Riedhammer KM; Schreiber JM; Sirsi D; Wierenga KJ; Wojcik MH; Papuc SM; Steindl K; Sticht H; Rauch A
    Eur J Hum Genet; 2019 May; 27(5):747-759. PubMed ID: 30664714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ATP1A3 variants and slowly progressive cerebellar ataxia without paroxysmal or episodic symptoms in children.
    Sasaki M; Sumitomo N; Shimizu-Motohashi Y; Takeshita E; Kurosawa K; Kosaki K; Iwama K; Mizuguchi T; Matsumoto N
    Dev Med Child Neurol; 2021 Jan; 63(1):111-115. PubMed ID: 32895939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.
    Cheng H; Dharmadhikari AV; Varland S; Ma N; Domingo D; Kleyner R; Rope AF; Yoon M; Stray-Pedersen A; Posey JE; Crews SR; Eldomery MK; Akdemir ZC; Lewis AM; Sutton VR; Rosenfeld JA; Conboy E; Agre K; Xia F; Walkiewicz M; Longoni M; High FA; van Slegtenhorst MA; Mancini GMS; Finnila CR; van Haeringen A; den Hollander N; Ruivenkamp C; Naidu S; Mahida S; Palmer EE; Murray L; Lim D; Jayakar P; Parker MJ; Giusto S; Stracuzzi E; Romano C; Beighley JS; Bernier RA; Küry S; Nizon M; Corbett MA; Shaw M; Gardner A; Barnett C; Armstrong R; Kassahn KS; Van Dijck A; Vandeweyer G; Kleefstra T; Schieving J; Jongmans MJ; de Vries BBA; Pfundt R; Kerr B; Rojas SK; Boycott KM; Person R; Willaert R; Eichler EE; Kooy RF; Yang Y; Wu JC; Lupski JR; Arnesen T; Cooper GM; Chung WK; Gecz J; Stessman HAF; Meng L; Lyon GJ
    Am J Hum Genet; 2018 May; 102(5):985-994. PubMed ID: 29656860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diverse functional consequences of mutations in the Na+/K+-ATPase alpha2-subunit causing familial hemiplegic migraine type 2.
    Tavraz NN; Friedrich T; Dürr KL; Koenderink JB; Bamberg E; Freilinger T; Dichgans M
    J Biol Chem; 2008 Nov; 283(45):31097-106. PubMed ID: 18728015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A de novo p.Arg756Cys mutation in ATP1A3 causes a distinct phenotype with prolonged weakness and encephalopathy triggered by fever.
    Nakamura Y; Hattori A; Nakashima M; Ieda D; Hori I; Negishi Y; Ando N; Matsumoto N; Saitoh S
    Brain Dev; 2018 Mar; 40(3):222-225. PubMed ID: 29066118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. De novo DDX3X missense variants in males appear viable and contribute to syndromic intellectual disability.
    Nicola P; Blackburn PR; Rasmussen KJ; Bertsch NL; Klee EW; Hasadsri L; Pichurin PN; Rankin J; Raymond FL; ; Clayton-Smith J
    Am J Med Genet A; 2019 Apr; 179(4):570-578. PubMed ID: 30734472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biochemical characterization of sporadic/familial hemiplegic migraine mutations.
    Weigand KM; Swarts HG; Russel FG; Koenderink JB
    Biochim Biophys Acta; 2014 Jul; 1838(7):1693-700. PubMed ID: 24704353
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An Infant With Epilepsy and Recurrent Hemiplegia due to Compound Heterozygous Variants in ATP1A2.
    Wilbur C; Buerki SE; Guella I; Toyota EB; Evans DM; McKenzie MB; Datta A; Michoulas A; Adam S; Van Allen MI; Nelson TN; Farrer MJ; Connolly MB; Demos M
    Pediatr Neurol; 2017 Oct; 75():87-90. PubMed ID: 28811059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early Treatment in Acute Severe Encephalopathy Caused by ATP1A2 Mutation of Familial Hemiplegic Migraine Type 2: Case Report and Literature Review.
    Du Y; Li C; Duan FJ; Zhao C; Zhang W
    Neuropediatrics; 2020 Jun; 51(3):215-220. PubMed ID: 31766058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition.
    Arystarkhova E; Haq IU; Luebbert T; Mochel F; Saunders-Pullman R; Bressman SB; Feschenko P; Salazar C; Cook JF; Demarest S; Brashear A; Ozelius LJ; Sweadner KJ
    Neurobiol Dis; 2019 Dec; 132():104577. PubMed ID: 31425744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemiplegic migraine type 2 caused by a novel variant within the P-type ATPase motif in ATP1A2 concomitant with a CACNA1A variant.
    Kubota T; Nabatame S; Sato R; Hama M; Nishiike U; Mochizuki H; Takahashi MP; Takeshima T
    Brain Dev; 2021 Oct; 43(9):952-957. PubMed ID: 34092402
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Variants in Mitochondrial ATP Synthase Cause Variable Neurologic Phenotypes.
    Zech M; Kopajtich R; Steinbrücker K; Bris C; Gueguen N; Feichtinger RG; Achleitner MT; Duzkale N; Périvier M; Koch J; Engelhardt H; Freisinger P; Wagner M; Brunet T; Berutti R; Smirnov D; Navaratnarajah T; Rodenburg RJT; Pais LS; Austin-Tse C; O'Leary M; Boesch S; Jech R; Bakhtiari S; Jin SC; Wilbert F; Kruer MC; Wortmann SB; Eckenweiler M; Mayr JA; Distelmaier F; Steinfeld R; Winkelmann J; Prokisch H
    Ann Neurol; 2022 Feb; 91(2):225-237. PubMed ID: 34954817
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Excess of de novo variants in genes involved in chromatin remodelling in patients with marfanoid habitus and intellectual disability.
    Chevarin M; Duffourd Y; A Barnard R; Moutton S; Lecoquierre F; Daoud F; Kuentz P; Cabret C; Thevenon J; Gautier E; Callier P; St-Onge J; Jouan T; Lacombe D; Delrue MA; Goizet C; Morice-Picard F; Van-Gils J; Munnich A; Lyonnet S; Cormier-Daire V; Baujat G; Holder M; Petit F; Leheup B; Odent S; Jouk PS; Lopez G; Geneviève D; Collignon P; Martin-Coignard D; Jacquette A; Perrin L; Putoux A; Sarrazin E; Amarof K; Missotte I; Coubes C; Jagadeesh S; Lapi E; Demurger F; Goldenberg A; Doco-Fenzy M; Mignot C; Héron D; Jean-Marçais N; Masurel A; El Chehadeh S; Marle N; Huet F; Binquet C; Collod-Beroud G; Arnaud P; Hanna N; Boileau C; Jondeau G; Olaso R; Lechner D; Poe C; Assoum M; Carmignac V; Duplomb L; Tran Mau-Them F; Philippe C; Vitobello A; Bruel AL; Boland A; Deleuze JF; Thauvin-Robinet C; Rivière JB; O'Roak BJ; Faivre L
    J Med Genet; 2020 Jul; 57(7):466-474. PubMed ID: 32277047
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A case of early onset life-threatening epilepsy associated with a novel ATP1A3 gene variant.
    Ishihara N; Inagaki H; Miyake M; Kawamura Y; Yoshikawa T; Kurahashi H
    Brain Dev; 2019 Mar; 41(3):285-291. PubMed ID: 30392841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and genetic analysis of six Chinese children with Poirier-Bienvenu neurodevelopmental syndrome caused by CSNK2B mutation.
    Yang S; Wu L; Liao H; Lu X; Zhang X; Kuang X; Yang L
    Neurogenetics; 2021 Oct; 22(4):323-332. PubMed ID: 34370157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A childhood-onset rapid-onset dystonia parkinsonism family with ATP1A3 gene mutation and literatures review].
    Zhang CL; Yin F; He F; Gai N; Shi ZQ; Peng J
    Zhonghua Er Ke Za Zhi; 2017 Apr; 55(4):288-293. PubMed ID: 28441826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.